Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

L-dopa challenge and relapse in schizophrenia.

M Davidson, R S Keefe, R C Mohs

    The American Journal of Psychiatry
    |July 1, 1987
    PubMed
    Summary

    This study found that L-dopa challenge can predict relapse in schizophrenia patients. Patients showing an increase in Brief Psychiatric Rating Scale scores after L-dopa were more likely to relapse sooner.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Real-world outcomes in patients with ALK-positive non-small cell lung cancer treated with crizotinib.

    Current oncology (Toronto, Ont.)·2018
    Same author

    Economic burden of diagnosed pertussis among individuals with asthma or chronic obstructive pulmonary disease in the USA: an analysis of administrative claims.

    Epidemiology and infection·2017
    Same author

    The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL.

    Leukemia·2017
    Same author

    Effect Of Sample Size And Data Maturity On Parametric Survival Modeling Projections In Advanced Cancer.

    Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
    Same author

    Dose Titration, Persistence, and Adherence to Statin Therapy Among Patients with High-Risk Vascular Disease in Japan.

    Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
    Same author

    Myelination, oligodendrocytes, and serious mental illness.

    Glia·2014

    Area of Science:

    • Psychiatry
    • Neuroscience
    • Pharmacology

    Background:

    • Neuroleptic medication is effective in maintaining remission for schizophrenia.
    • However, some patients relapse after neuroleptic withdrawal, while others maintain remission without medication.

    Purpose of the Study:

    • To predict relapse time in schizophrenia patients after neuroleptic withdrawal.
    • To assess the utility of L-dopa challenge as a predictor of relapse.

    Main Methods:

    • 28 schizophrenia patients were withdrawn from neuroleptics.
    • Patients underwent a 7-day L-dopa challenge.
    • Time to relapse was monitored after the challenge.

    Main Results:

    • Time to relapse significantly correlated with L-dopa-induced increase in Brief Psychiatric Rating Scale (BPRS) scores (p = .006).

    Related Experiment Videos

  • Five of six patients who responded to L-dopa relapsed within 4 weeks.
  • Only four of 22 non-responders relapsed in the same period.

    • Conclusions:

    • L-dopa challenge can predict relapse in schizophrenia.
    • Increased BPRS scores after L-dopa indicate a higher risk of early relapse.
    • This finding may inform personalized treatment strategies for schizophrenia patients.